加拿大安大略省类风湿关节炎初级保健筛查与共病管理质量评估
该研究基于加拿大安大略省初级保健电子病历数据库,比较1,405例RA患者与14,050例年龄性别匹配的非RA患者的共病筛查与管理质量指标。结果显示RA患者流感疫苗接种、肺炎球菌疫苗接种和骨密度检测率高于非RA患者,但带状疱疹疫苗接种和宫颈癌筛查率较低,仅约四分之一RA患者接受全面心血管风险评估。作者结论为两类患者对加拿大预防保健推荐依从性均不理想。
要点
- RA患者流感疫苗接种率44.9%、肺炎球菌疫苗40.4%、骨密度检测67.4%,均高于非RA患者。
- RA患者带状疱疹疫苗接种率13.8%、宫颈癌筛查率58.6%,低于非RA患者。
- 仅约四分之一RA患者接受全面心血管风险评估,乳腺癌和结直肠癌筛查无显著差异。
核心结论
- RA和非RA患者对加拿大预防保健服务和共病筛查推荐的依从性均不理想,提示需改进。
研究设计与样本
- 基于加拿大安大略省初级保健电子病历关联数据库的匹配队列研究,比较1,405例RA患者与14,050例年龄性别匹配的非RA患者。
- 整合加拿大普通人群和RA临床推荐,制定并评估筛查、过程和结局质量指标。
主要发现
- RA患者较非RA患者更频繁接受流感疫苗接种(44.9% vs 40.0%)、肺炎球菌疫苗接种(40.4% vs 34.1%)和骨密度检测(67.4% vs 58.1%)。
- RA患者带状疱疹疫苗接种率较低(13.8% vs 19.5%),宫颈癌筛查率较低(58.6% vs 64.0%)。
- 乳腺癌筛查(70.7% vs 73.8%)和结直肠癌筛查(31.7% vs 34.5%)在RA与非RA患者间无显著差异。
- 仅约四分之一RA患者接受全面心血管风险评估,合并心血管疾病或糖尿病患者的管理未见明确差异。
临床怎么用
- 初级保健中应加强RA患者带状疱疹疫苗接种和宫颈癌筛查的落实。
- 应提高RA患者全面心血管风险评估的实施率。
- RA患者流感疫苗、肺炎球菌疫苗和骨密度检测覆盖率虽高于非RA人群,但仍有提升空间。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Quality measurement for rheumatoid arthritis (RA) patients has largely focused on care provided by rheumatologists. Our aim was to develop and assess quality measures related to the screening and management of comorbidity in RA patients in primary care. METHODS: We used the primary care Electronic Medical Record Administrative data Linked Database in Ontario, Canada. We harmonized Canadian general population and RA clinical recommendations to develop and assess screening, process, and outcome measures. For each RA patient, 10 non-RA patients were matched by age and sex. Stratified analyses were performed, comparing patients with RA to those without RA, to assess the performance of quality measures. RESULTS: We compared 1,405 RA patients to 14,050 matched non-RA patients (72.8% female; mean age 62.5 years). Compared to non-RA patients, RA patients more frequently had influenza (44.9% versus 40.0%) and pneumococcal (40.4% versus 34.1%) vaccinations and bone mineral density testing (67.4% versus 58.1%). Herpes zoster vaccinations were less frequent among RA patients (13.8% versus 19.5%), as was screening for cervical cancer (58.6% versus 64.0%). No significant differences were observed between RA and non-RA patients in screenings for breast (70.7% versus 73.8%) or colorectal (31.7% versus 34.5%) cancers. Only a quarter of RA patients had a comprehensive cardiovascular risk assessment. No definitive differences were detected in the management of patients who had co-occurring cardiovascular disease or diabetes mellitus. CONCLUSION: For both RA and non-RA patients, compliance with Canadian recommendations for preventive medical services and screening for comorbid conditions in primary care was less than optimal. This indicates key targets for improvement.
引用
- Widdifield J, Ivers NM, Bernatsky S, et al. Primary Care Screening and Comorbidity Management in Rheumatoid Arthritis in Ontario, Canada. Arthritis Care Res (Hoboken). 2017. PMID: 27998044. doi:10.1002/acr.23178
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。